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 Utilization of monoclonal antibodies belongs to one of the important strategies 
in the treatment of oncological diseases. This treatment has a great advantage in precise 
focusing on the target structure with minimal damage to surrounding non-target tissue. 
The antibodies against the receptor for epidermal growth factor (EGFR) expressed in 
higher rate by variety of tumor types represent one of the important group. Nowadays 
oncology utilizes both unconjugated antibodies, and the ones conjugated with other 
effector components, e.g. cytostatic agents, radionuclides, toxins. One of the important 
limits for the antibodies conjugated with radionuclides appears to be their potential 
accumulation in kidneys with subsequent radiotoxic damage to the kidney tissue. 
The aim of this experimental study was to investigate the accumulation of three 
131
I–
labeled anti-EGFR antibodies - panitumumab, cetuximab and nimotuzumab using a 
kidney model in vitro, and compare it with renal uptake of the natural peptide ligand 
EGFR which was labeled in the same manner (
131
I-EGF). Isolated rat kidney cells 
obtained by the collagenase perfusion method were used as an experimental in vitro 
model. Incubation under standard and lowered temperature (37 °C vs. 4 °C) was 
realized in order to assess the nature of the transport. The results of accumulation 
studies showed that for all three investigated antibodies labeled with 
131
I, the uptake 
in rat kidney cells was comparable. In comparison to the peptide 
131
I-EGF, the rate of 
accumulation of the labeled antibodies was much lower. The low incubation 
temperature did not lead to a significant decrease of accumulation, suggesting an 
insignificant contribution of active transport mechanisms to renal uptake. This result 
also confirms absence of a significant dependence of the uptake in the kidney cells 
on incubation time. The results obtained in vitro indicate low potential of studied 
iodine-131 labeled monoclonal antibodies for renal accumulation as well as passive 
nature of their renal uptake. 
